POPULARITY
2 episodes with lies the inside story
2 episodes with lies the inside story
2 episodes with lies the inside story
2 episodes with lies the inside story
Today on Change Agents, Andy Stumpf sits down with investigative journalist Katherine Eban. She is an award-winning investigative journalist and a Vanity Fair special correspondent, specializing in the pharmaceutical industry. She is the author of books including Dangerous Doses: A True Story of Cops, Counterfeiters and the Contamination of America's Drug Supply, as well as, Bottle of Lies: The Inside Story of the Generic Drug Boom. Katherine recently came into possession of emails between government officials concerned about the Wuhan Institute of Virology in the months and years leading up to the COVID-19 pandemic. She recently posted an explosive investigative report in Vanity Fair, titled: “Secret Warnings About Wuhan Research Predated the Pandemic” which you can read here: https://www.vanityfair.com/news/2023/11/covid-origins-warnings-nih-department-of-energy SPONSOR: Change Agents is presented by Montana Knife Company. Use CODE "CHANGEAGENTS10" for 10% off your first order at https://www.montanaknifecompany.com/ MTNTOUGH Go to https://mtntough.com and enter code CHANGEAGENTS to receive 40% OFF - a savings of about $100 your MTNTOUGH+ annual subscription. Shop IRONCLAD Apparel: https://shop.thisisironclad.com/ Change Agents is an IRONCLAD original. Visit https://www.thisisironclad.com to learn more. Be sure to subscribe to @thisisironclad on YouTube and major social platforms.
On this episode, I was joined by Katherine Eban, the New York Times best-selling author of "Bottle of Lies". In this episode, Katherine dives deep into her decade-long investigation into the quality issues prevalent in generic drug manufacturing overseas. Eban highlights the need for improving transparency in the pharmaceutical industry. She shares some inspiring stories of dedicated professionals in the industry who strive to ensure patients receive quality. Eban also discusses her findings on fraudulent practices in manufacturing plants and the role of quality data in drug production. The episode sheds light on the importance of understanding the manufacturing process behind generic drugs and critical quality control issues needing urgent attention. Time-Stamps: 02:12 The Start of the Investigation into Generic Drug Quality 08:59 The Impact of Quality Issues on Global Health 12:54 Understanding the FDA's Role in Drug Quality Control 16:55 The Struggle to Maintain Quality in the Pharmaceutical Industry 18:39 The Ranbaxy Story 27:45 Peter Baker 30:19 Quality Stories 33:27 Conclusion and Final Thoughts Link to Katherine's Book: Bottle of Lies: The Inside Story of the Generic Drug Boom, is a New York Times bestseller and one of the New York Times' 100 Notable Books of 2019.
Show Notes:Question #1: I have a couple of clients with Parkinson and also clients over the age of 80+. As you know, most doctors aren't easy to get on board with proactive health care.Can you please send me the reference or do you have any books or other research I could share with doctors to get them on board?Research Review: https://movementdisorders.onlinelibrary.wiley.com/doi/epdf/10.1002/mds.21922- The Brain That Changes Itself: Stories of Personal Triumph from the Frontiers of Brain Science by Norman Doidge- The Tale of the Dueling Neurosurgeons: The History of the Human Brain as Revealed by True Stories of Trauma, Madness, and Recovery by Sam Kean- Spark: The Revolutionary New Science of Exercise and the Brain by John J. Ratey MD- Life span vs. Health Span- Visualization & Meditation = Mirror Neurons- Let movement be thy medicine. Let mindset be thy medicine. Let nature be thy medicine. Let medicine be thy medicine.Question #2: What are your key considerations when training endurance athletes? I'm specifically interested in learning about how you approach both strength and conditioning for clients who are preparing for long-distance running events like the marathon.Coach Matt DixonBuckets for Endurance: Run, Bike, Swim / Recovery / Nutrition & Fueling/ StrengthTraining Buckets: Mobility / Strength / Power / ConditioningBe A Bucket Filler by Michael BoyleThe Bucket Hierarchy by Brendon RearickThe 10% Rule… don't increase more that 10% in distance or intensity per weekFunctional Training for Runners by Kevin CarrMake Small Jumps by Michael BoyleEndurance athletes are almost always in-seasonBook Club recommendation:Kevin: Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine EbanBrendon: Why Michael Couldn't Hit: And Other Tales of the Neurology of Sports by Harold L. KlawansWhere you can find us next:Upcoming Level 2 CFSC events - Boston, Chicago then Reading, PAPerform Better Summits - Chicago July 15th - 17th then Providence August 26th - 28th
Growing up I remember my mother telling me I shouldn't drink coffee because it could stunt my growth. Really? How could that possibly be true? Also, people have long believed that coffee will sober up someone who has been drinking. Can coffee really do that too? This episode begins with a look at what coffee can and cannot do. http://lifehacker.com/four-popular-coffee-myths-debunked-by-science-1780764499 Why would you pay for name brand drug when a generic version is cheaper? After all, generic drugs are equivalent to name brands - right? That's the question I explore with journalist Katherine Eban, author of the book Bottle of Lies: The Inside Story of the Generic Drug Boom (https://amzn.to/2K1f6Vm). We have all been told that generic drugs are the same - or at least have the same active ingredient as name brand drugs at a fraction of the price. However, they may not necessarily be true. Katherine's investigation found a disturbing story about the safety and effectiveness of generic drugs that you probably haven't heard before. If you or a friend or family member takes prescription drugs, it is important for you to hear this episode. Katherine's website is www.KatherineEban.com Too much sun is a problem. But so is too little sun. It turns out there is strong medical evidence that some sun is good for your health. Listen to hear how much and what it is good for. (http://www.rd.com/health/wellness/sun-affects-your-body/) Finding the right job or even figuring out what career path to take is challenging and often difficult. However, there is some good research in this area that can help you find a job, do it well and move up the ladder. One of the experts in this field is Art Markman, professor of Psychology and Marketing at the University of Texas at Austin and author of the book Bring Your Brain To Work: Using Cognitive Science to Get a Job, Do It Well and Advance Your Career (https://amzn.to/2WpTbc6). Listen as Art joins me for a fascinating look at a better way to find professional success. PLEASE SUPPORT OUR SPONSORS! We really like The Jordan Harbinger Show! Check out https://jordanharbinger.com/start OR search for it on Apple Podcasts, Spotify or wherever you listen! Helix Sleep is offering up to $200 off all mattress orders AND two free pillows for our listeners at https://helixsleep.com/sysk. Discover matches all the cash back you've earned at the end of your first year! Learn more at https://discover.com/match M1 Finance is a sleek, fully integrated financial platform that lets you manage your cash flow with a few taps and it's free to start. Head to https://m1finance.com/something to get started! Download Best Fiends FREE today on the App Store or Google Play! To TurboTax Live Experts an interesting life can mean an even greater refund! Visit https://TurboTax.com to lear more. To see the all new Lexus NX and to discover everything it was designed to do for you, visit https://Lexus.com/NX Grab a Focus Freak Milkshake for 3.99 or less! And use offer code ENERGIZE to save $1 when you order on the Sheetz app! https://www.geico.com Bundle your policies and save! It's Geico easy! Learn more about your ad choices. Visit megaphone.fm/adchoices
This week we are taking a look at the Singh brothers. Malvinder Mohan Singh and Shivinder Mohan Singh the heirs to a generic pharmaceutical company that would be responsible for providing Africans with AIDS, junk drugs. A major source for this episode was A Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban. Sean is slowly being radicalized by RFK so a significant portion is spent on new theories as to why the world sucks. All that and more right here on Grubstakers. Check out Grubstakers.net for a full list of our resources on this and every other episode. Enjoy!
Katherine Eban is an investigative journalist and contributor to Vanity Fair. Her latest article is ”The Lab-Leak Theory: Inside the Fight to Uncover COVID-19's Origins.””You can't make a correction unless you know why something happened. So imagine—if this is a lab leak—the earth shattering consequences for virology. For the science community, for how research is done, for how research is regulated. Or if it is a zoonotic origin, we have to know how our human incursion into wild spaces could be unleashing these viruses. Because COVID-19 is one thing, but we're going to be looking at COVID-25 and COVID-34. We have to know what caused this.” Thanks to Mailchimp for sponsoring this week's episode. Show notes: @KatherineEban katherineeban.com Eban on Longform Eban on Longform Podcast 00:00 Bottle of Lies: The Inside Story of the Generic Drug Boom (Ecco • 2019) 00:00 "The Lab-Leak Theory: Inside the Fight to Uncover COVID-19's Origins" (Vanity Fair • Jun 2021) 01:00 Nicholson Baker on Longform Podcast 01:00 "The Lab-Leak Hypothesis" (Nicholson Baker • New York Magazine • Jan 2021) 03:00 "The Plague Fighters: Stopping the Next Pandemic Before It Begins " (Evan Ratliff • Wired • Apr 2007) 12:00 @TheSeeker268 14:00 Eban's Vanity Fair archive 16:00 Eban's Twitter thread 26:00 Alina Chan on Twitter 32:00 "Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19" (Peter Daszak and many others • The Lancet • Feb 2020) 34:00 "Origin of Covid — Following the Clues" (Nicholas Wade • Medium • May 2021) See omnystudio.com/listener for privacy information.
Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban KatherineEban.com A NEW YORK TIMES BESTSELLER New York Times 100 Notable Books of 2019 New York Public Library Best Books of 2019 Kirkus Reviews Best Health and Science Books of 2019 Science Friday Best Books of 2019 New postscript by the author From an award-winning journalist, […] The post Book Author Podcast – Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban appeared first on Book Author Podcast.
Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban KatherineEban.com A NEW YORK TIMES BESTSELLER New York Times 100 Notable Books of 2019 New York Public Library Best Books of 2019 Kirkus Reviews Best Health and Science Books of 2019 Science Friday Best Books of 2019 New postscript by the author From an award-winning journalist, […] The post Chris Voss Podcast – Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban appeared first on Chris Voss Official Website.
On this week's Science Revolution is Dr. Jason Hill with the University of Minnesota- he says cutting greenhouse gases from food production is urgent & that our food systems may be the "dark horse of climate change." Investigative Journalist Katherine Eban drops by on her new book, 'Bottles of Lies: The Inside Story of the Generic Drug Boom'. Mari Margil, with the Center for Democratic and Environmental Rights, will be telling us about the huge win in Florida for the "rights of Nature." Stay tuned.
Katherine Eban - Bottle of Lies: The Inside Story of the Generic Drug Boom...with TRE's Selina Mackenzie
Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban KatherineEban.com A NEW YORK TIMES BESTSELLER New York Times 100 Notable Books of 2019 New York Public Library Best Books of 2019 Kirkus Reviews Best Health and Science Books of 2019 Science Friday Best Books of 2019 New postscript by the author From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles. About Katherine Eban Katherine Eban, an investigative journalist, is a Fortune magazine contributor and Andrew Carnegie fellow. Her narrative, deeply reported articles on pharmaceutical counterfeiting, gun trafficking, and coercive interrogations by the CIA, have won international attention and numerous awards. She lectures frequently on the topic of pharmaceutical integrity. Bottle of Lies: The Inside Story of the Generic Drug Boom, which she worked on for five years and reported on four continents, is her second book. Educated at Brown University and Oxford, where she was a Rhodes Scholar, she lives in Brooklyn with her husband, two daughters and Newfoundland dog Romeo.
Virginia Heffernan talks to Katherine Eban, contributing editor for Vanity Fair and author of Bottle of Lies: The Inside Story of the Generic Drug Boom, about her recent piece on Jared Kushner’s botched COVID-19 response, and what happened when she followed a suspicious trail of his receipts. Learn more about your ad choices. Visit megaphone.fm/adchoices
Virginia Heffernan talks to Katherine Eban, contributing editor for Vanity Fair and author of Bottle of Lies: The Inside Story of the Generic Drug Boom, about her recent piece on Jared Kushner’s botched COVID-19 response, and what happened when she followed a suspicious trail of his receipts. Learn more about your ad choices. Visit megaphone.fm/adchoices
Live Broadcast of the U.S. Health Subcommittee of the House Energy and Commerce Committee hearing: “Protecting Scientific Integrity in the COVID-19 Response (Panel I). Witnesses Richard A. Bright, Ph.D. Senior Advisor National Institutes of Health –Testimony Hosts: Mitch Jeserich, Cat Brooks, and Brian Edwards-Tiekert. Guests: Zain Rizvi, Law and Policy Researcher with Public Citizen. He is an expert on drug pricing, access to medicines and global health. Tom Devine is the Legal Director of the Government Accountability Project. Katherine Eban, is an investigative journalist and author. She is a Vanity Fair contributor. Her latest book is Bottle of Lies: The Inside Story of the Generic Drug Boom The post Special Broadcast – U.S. House Hearing on Protecting Scientific Integrity in the COVID-19 Response appeared first on KPFA.
Medicines. We all need to take them. And it seems like the prices are just getting higher and higher. Luckily, generics offer a cheaper alternative. And we are told that they are both the same drug and do the same thing, we assume in the same way. But it turns out that's not really quite true. This week, we're talking with Katherine Eban about her book "Bottle of Lies: The Inside Story of the Generic Drug Boom". Related links: After a scandal, a one-sided warning against generic drugs by Jeremy Greene in The Washington Post Ranbaxy's empty promises by Katherine...
Today’s interview is with Katherine Eban, an investigative journalist who uncovered the widespread fraud that goes on overseas in the manufacturing of U.S. generic drugs. With the outbreak of the deadly coronavirus, which originated in China but is now spreading across the globe and United States, today’s interview is especially timely. Katherine’s recent book, “Bottle of Lies,” reveals that nearly 80 percent of the active ingredients of all brand-name and generic drugs as well as almost all of our antibiotics in the U.S. are made outside of the country, mostly in China and India. Today’s interview highlights the dangers Americans face in outsourcing the quality and safety of its brand-name and generic drugs to overseas manufacturers. Katherine is an investigative journalist who has written award-winning stories that range from pharmaceutical counterfeiting to gun trafficking to even coercive interrogations by the CIA. Her first book, “Dangerous Doses: A True Story of Cops, Counterfeiters and the Contamination of America’s Drug Supply,” was named one of the Best Books of 2005 by Kirkus Reviews. “Bottle of Lies: The Inside Story of the Generic Drug Boom” is a New York Times bestseller that came out in 2019 and was named one of the top 100 notable books of 2019 by the Times. Show notes: [00:03:16] Dawn opens the interview mentioning Katherine’s appearance on Peter Attia’s podcast. [00:04:30] Ken asks how Katherine how she ended up living just three subway stops from where she grew up in Brooklyn. [00:05:01] Katherine talks about how despite her talent and interest in writing, she at one point joined the circus in high school and considered going to clown school after she graduated. [00:06:02] Dawn asks how Katherine ended up in Rhode Island to attend Brown University instead of going to Florida to attend the Ringling Brothers Clown College. [00:06:47] Katherine talks about her time at Brown University editing the school’s literary magazine. [00:07:24] Ken Asks about Katherine’s time at Oxford University as a Rhodes scholar. [00:08:37] Dawn asks how Katherine, a woman who holds a Master’s degree in 17th Century English Epic Civil War Poetry, became a journalist. [00:10:23] Dawn asks about Katherine’s first big story, which also happened to be her first story. [00:11:49] Dawn asks Catherine long she worked at the New York Times. [00:13:07] Katherine explains how she came to write her first book, “Dangerous Doses: A True Story of Cops, Counterfeiters and the Contamination of America’s Drug Supply.” [00:14:56] Dawn mentions that after the publishing of “Dangerous Doses,” Katherine spent a decade investigating the generic-drug industry, an investigation sparked by a phone call from a colleague who asked for her help. [00:16:17] Ken asks about the difference between a generic and brand-name drug, and what is involved in the process of reverse-engineering a drug. [00:17:43] Dawn asks about the series of interviews Katherine conducted with patients sharing their experiences with generic drugs, which led to a story she wrote for “Self” magazine in 2009. [00:20:15] Ken mentions that in the “Self” magazine article, Katherine wrote about Dr. Kesselheim, an instructor at Harvard Medical school who reviewed data from 47 clinical studies. He found no evidence that patients on brand-name cardiovascular drugs had outcomes superior to those on generics. Given this study is now 10 years old, Ken asks if anyone has revisited this analysis. [00:21:25] Katherine tells the story of her anonymous informant that contacted her about a month after the “Self” magazine article, who went by the pseudonym “4 Dollar Refill.” [00:22:38] Dawn mentions that over the following five years, Katherine wrote a series of articles about generic-drug quality, which culminated in a 10,000-word article titled “Dirty Medicine” published in Fortune Magazine in 2013.
So, you think the FDA is closely regulating all those generic drugs? Think again. Can you handle the truth? In this “in-between-isode” MedPage's new Editor-in-Chief Marty Makary, MD, MPH, interviews author Katherine Eban about her recently published book, Bottle of Lies: The Inside Story of the Generic Drug Boom. Episode produced by MedPage Staff Hosted and sound engineering by Greg Laub
90 percent of the world’s pharmaceutical market is comprised of generic drugs. Generics have been hailed as low-cost alternatives to their more expensive brand-name counterparts, thereby providing low-income patients around the world with affordable medicines.An explosive new book, Bottle of Lies: The Inside Story of the Generic Drug Boom, by journalist Katherine Eban demolishes this myth and provides a dizzying, page-turning investigation of the lies, deceit, and outright fraud that run rampant in the generics industry. The narrative arc of the book is built around the rapid rise and the dramatic decline of the Indian generics manufacturer Ranbaxy.This week, Milan speaks with Katherine to discuss her decade-long investigation, the contested role that India plays, and the consequences for public health.
Host: Maurice Pickard, MD Guest: Katherine Eban Joining Dr. Maurice Pickard is award-winning journalist and author of Bottles of Lies: The Inside Story of the Generic Drug Boom Katherine Eban, who investigates the health concerns that are beginning to surface on a global scale due to the rise in generic drug use.
Host: Maurice Pickard, MD Guest: Katherine Eban Joining Dr. Maurice Pickard is award-winning journalist and author of Bottles of Lies: The Inside Story of the Generic Drug Boom Katherine Eban, who investigates the health concerns that are beginning to surface on a global scale due to the rise in generic drug use.
Katherine Eban’s new book, Bottle of Lies, is terrifying. Here’s why: 90 percent of our pharmaceutical market is comprised of generics. Without generic medications, drug prices would not just be a problem, but literally a killer. And our doctors tell us these drugs are safe. But, according to Katherine, we actually cannot trust generic drugs. Find out why, in this chilling episode. Katherine is a long-time investigative reporter who focuses on public health and homeland security and sits down with Bethany to discuss the astonishing fraud and side effects of the generic drug boom. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Listen NowNine in 10 prescriptions are today filled using a generic drug saving Americans tens of billions annually. A significant amount of generic drugs, along with active ingredients in all drugs, are manufactured overseas. However, how safely or to what quality standards are these ingredients and generics produced? Bottle of Lies, published in May, tells the story of appalling practices foreign generic manufacturers use to produce these drugs at the most minimal cost. The work moreover provides a detailed account of Ranbaxy, the former India-based generic manufacturer that after eight years of investigation was fined a then record amount,$500 million, for significant fraud. The work questions or brings to serious doubt the FDA's ability to adequately inspect overseas generic manufacturers ensuring these drugs are safe for consumption in the US or around the world. Listeners may recall I interviewed coauthor Paul Weinberg in September 2017 concerning his related work, Blood On Their Hands, How Greedy Companies, Inept Bureaucracy and Bad Science Killed Thousands of Hemophiliacs and Rosemary Gibson this past December concerning her related, China Rx, Exposing the Risk of America's Dependence on China for Medicine. During this 37 minute interview. Ms. Eban provides an overview of Ranbaxy's manufacturing practices revealed by former employee and whistleblower, Dinesh Thakur. She explains the mindset, termed "Jugaad," used in India to produce generics. She discusses the adequacy of the 2013 US settlement with Ranbaxy , the role the Japanese firm, Daiichi Sankyo, a major Ranbaxy stakeholder, the FDA's ability to adequately inspect Ranbaxy and other generic manufacturers around the world, e.g., Cipla and Mylan, recent and future related Congressional action, how poor or inadequate manufacturing practices complicate remedying the drug shortage problem and what precautions consumers or patients can take before consuming generic drugs. Katherine Eban, an investigative journalist, is a Fortune magazine contributor and Andrew Carnegie fellow. Her articles on pharmaceutical counterfeiting, gun trafficking, and coercive interrogations by the CIA, have won international attention and numerous awards. She has also written for Vanity Fair, The New York Times, Self, The Nation, the New York Observer and other publications. Her work has been featured on 60 Minutes, Nightline, NPR, and other national news programs. She lectures frequently on the topic of pharmaceutical integrity. Her first book, Dangerous Doses: a True Story of Cops, Counterfeiters and the Contamination of America's Drug Supply, was named one of the Best Books of 2005 by Kirkus Reviews and was a Barnes&Noble Discover Great New Writers pick. Her account of reporting on 9/11 was anthologized in At Ground Zero: 25 Stories From Young Reporters Who Were There. Her work has also been awarded grants from the Alfred P. Sloan Foundation, the Fund for Investigative Journalism, the Alicia Patterson Foundation and the McGraw Center for Business Journalism at CUNY's Craig Newmark Graduate School of Journalism. Educated at Brown University and Oxford, where she was a Rhodes Scholar. Information on Bottle of Lies is at: https://www.harpercollins.com/9780062338785/bottle-of-lies/. Ms. Eban's FAQ regarding how to learn about generics or best to consume is at: https://www.katherineeban.com/faqs. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com
According to investigative journalist, Katherine Eban, there is a lot of fraud going on with generic medications -- putting patient safety at risk.Today, 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas.The thought is that these drugs are as effective as their brand-name counterparts, just less expensive. Is that really true?According to investigative journalist, Katherine Eban, there is a lot of fraud going on with these generic medications. Her book, Bottle of Lies: The Inside Story of the Generic Drug Boom, exposes the deceit behind generic drug manufacturing. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.Listen as Eban joins Dr. Roizen to explain how this could happen -- and what can be done to change the process and ultimately ensure the health and safety of those who consume generics.BonusSurprising Mental Side Effects of Pain Relievers
Knowledge is power. Join Dr. Berkson's interview with KATHERINE EBAN, an investigative journalist, Fortune magazine contributor, Andrew Carnegie fellow, and New York Time’s best-selling author of Bottle of Lies: The Inside Story of the Generic Drug Boom and expand your knowledge base. Ms. Eban is known and respected for lecturing on pharmaceutical counterfeiting and pharmaceutical integrity, or lack of it. And… now… generic medications. In this illuminating and must-hear show you will learn: What are generic drugs and what are the concerns with them. Where you can go to figure out the deep dive on your own generic meds. How is the FDA letting us down and what are the conflicts of interest? 80% of our generics are made overseas, mostly in India and China, who often have very serious issues with their chemical plants, contaminants and other complications. The U.S. makes almost none of its own antibiotics anymore. Examples of fraud committed by generic-drug makers at manufacturing plants in India and China include: forging of documents and data to prove that generic drugs are equivalent to brand-name drugs, when they’re not; altering of test parameters so that formulations with higher impurities can be approved; superimposing brand-name test results onto generic results in applications to regulators. Overseas drug companies take extreme measures to evade FDA scrutiny. At one major U.S. hospital center, transplant surgeons found that their patients suffered organ rejection after taking an immunosuppressant medication made by an Indian generic drug company. Poor-quality generic drugs are feeding the epidemic of drug resistance around the world. Links: https://www.katherineeban.com/guide https://www.katherineeban.com/faqs
Brodesser-Akner discusses “Fleishman in Trouble,” and Katherine Eban talks about “Bottle of Lies: The Inside Story of the Generic Drug Boom.”
http://traffic.libsyn.com/radiohealthjournal/RHJ_19-25A.mp3 Since the 1980’s, almost all production of generic drugs has moved overseas, where FDA inspectors have a much tougher time making sure they’re following rules for safety. Slightly more than half of all Americans take prescription drugs, and 90 percent of those drugs are generic. The FDA inspects health regulations and data in drug manufacturing companies to ensure the safety and quality of the environment and the actual drugs. Unfortunately some companies worry less about the safety of the people using the drugs and more about speedy production and high profit margins. Investigative journalist Katherine Eban uncovers the alarming level of fraud and deception that some generic drug companies have achieved in her new book, Bottle of Lies: The Inside Story of the Generic Drug Boom. Eban conducted research for the book by following an FDA inspector through the process of exposing fraudulent practices at Indian and Chinese generic drug manufacturing plants. According to Eban, this investigator saw past the diversions, looking at the internal computer systems where he uncovered clear-cut data tampering. It turns out there was fraudulent quality data in 67 of the 86 plants the FDA inspector investigated in India and China over five years. But it’s more than just data tampering. Basic health regulations like maintaining a sterile environment are often violated. Eban says there are cases where work spaces don’t even have bathrooms with running water, making it impossible for the employees to wash their hands. Part of this problem is globalization. It’s harder for the FDA to investigate international plants. According to Eban, they’re often given notice a month or more in advance of an upcoming inspection, while companies in the United States have inspectors stop-in without any prior knowledge. Some Chinese companies will even pool resources to set up “show” plants, causing regulators to inspect manufacturers completely independent from the intended locations. In some countries, such as the United Kingdom and Italy, the FDA relies entirely on inspectors from those countries. As it stands, patients are at the mercy of the companies producing the final product that’s handed to them at the drugstore. It’s nearly impossible to test every single pill as it comes into the U.S., and that’s why Eban says it’s so crucial that the common practice of fabricating fraudulent manufacturing data is curbed. So what can be done? Right now, the onus is on consumers to research the companies producing our generics. Eban says the easiest way to do this is find the name of the manufacturer on your prescription label, then Google it along with the terms ‘FDA’ and ‘warning letter’. In some cases, that’s the most that can be done, at least until laws are changed. Further information can be found at https://www.katherineeban.com/new-page. Guest: Katherine Eban, author, Bottle of Lies: The Inside Story of the Generic Drug Boom Links for more information: More about Katherine Eban Learn more about how to research generic drugs
http://traffic.libsyn.com/radiohealthjournal/Reed_Generics_conversation.mp3 Reed Pence speaks with investigative Reporter Katherine Eband, author of Bottle of Lies: The Inside Story of the Generic Drug Boom about the quality of regulation of generic drugs. Featuring: Reed Pence, host of Radio Health Journal Katherine Eban, author, Bottle of Lies: The Inside Story of the Generic Drug Boom
In an eclectic program, Ralph talks first with Rebecca Sheir and Eric Shimelonis, creators of the podcast “Circle Round,” which adapts and updates folk-tales for children. Then, investigative reporter Katherine Eban joins us to talk about her exposé: “Bottle of Lies: The Inside Story of the Generic Drug Boom.”
Kathryn interviews Investigative Journalist Katherine Eban, NY Times Best-Selling author of “Bottle of Lies: The Inside Story of the Generic Drug Boom.” Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. Eban reveals an industry where fraud is rampant and companies routinely falsify data. Her work has been featured in Vanity Fair, NY Times, Self, The Nation, the New York Observer, 60 Minutes, Nightline, NPR, and more. Kathryn also interviews Lawyer Annette Hines Esq, author of “Butterflies and Second Chances: A Mom's Memoir of Love and Loss.” Not only can taking care of a child with a disability seem like an insurmountable task for many, but making sure their child has a secure future when they are no longer there can seem daunting as well. Hines is a powerhouse advocate for the special needs community and has been practicing in the areas of Special Needs, Elder Law and Estate Planning for over twenty years.
Kathryn interviews Investigative Journalist Katherine Eban, NY Times Best-Selling author of “Bottle of Lies: The Inside Story of the Generic Drug Boom.” Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. Eban reveals an industry where fraud is rampant and companies routinely falsify data. Her work has been featured in Vanity Fair, NY Times, Self, The Nation, the New York Observer, 60 Minutes, Nightline, NPR, and more. Kathryn also interviews Lawyer Annette Hines Esq, author of “Butterflies and Second Chances: A Mom's Memoir of Love and Loss.” Not only can taking care of a child with a disability seem like an insurmountable task for many, but making sure their child has a secure future when they are no longer there can seem daunting as well. Hines is a powerhouse advocate for the special needs community and has been practicing in the areas of Special Needs, Elder Law and Estate Planning for over twenty years.
Kathryn interviews Investigative Journalist Katherine Eban, NY Times Best-Selling author of “Bottle of Lies: The Inside Story of the Generic Drug Boom.” Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. Eban reveals an industry where fraud is rampant and companies routinely falsify data. Her work has been featured in Vanity Fair, NY Times, Self, The Nation, the New York Observer, 60 Minutes, Nightline, NPR, and more. Kathryn also interviews Lawyer Annette Hines Esq, author of “Butterflies and Second Chances: A Mom's Memoir of Love and Loss.” Not only can taking care of a child with a disability seem like an insurmountable task for many, but making sure their child has a secure future when they are no longer there can seem daunting as well. Hines is a powerhouse advocate for the special needs community and has been practicing in the areas of Special Needs, Elder Law and Estate Planning for over twenty years.
Kathryn interviews Investigative Journalist Katherine Eban, NY Times Best-Selling author of “Bottle of Lies: The Inside Story of the Generic Drug Boom.” Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. Eban reveals an industry where fraud is rampant and companies routinely falsify data. Her work has been featured in Vanity Fair, NY Times, Self, The Nation, the New York Observer, 60 Minutes, Nightline, NPR, and more. Kathryn also interviews Lawyer Annette Hines Esq, author of “Butterflies and Second Chances: A Mom's Memoir of Love and Loss.” Not only can taking care of a child with a disability seem like an insurmountable task for many, but making sure their child has a secure future when they are no longer there can seem daunting as well. Hines is a powerhouse advocate for the special needs community and has been practicing in the areas of Special Needs, Elder Law and Estate Planning for over twenty years.
This week Alice and Kim talk about witches, Jehovah’s Witnesses, fungus-inspired crime, and what nonfiction to read for Pride Month. This episode is sponsored by All the Books, The Collected Schizophreniasby Esmé Weijun Wang, and Houghton Mifflin Harcourt, publishers of Reckoning: The Epic Battle Against Sexual Abuse and Harassment by Linda Hirshman. Subscribe to For Real using RSS, Apple Podcasts, or Stitcher. For more nonfiction recommendations, sign up for our True Story newsletter, edited by Kim Ukura. Follow Up KIM: Slow Burn podcast is doing a series on The Queen by Josh Levin (one of the editor’s behind Slow Burn) New Books Leaving the Witness: Exiting a Religion and Finding a Life by Amber Scorah Waking the Witch: Reflections on Women, Magic, and Power by Pam Grossman This Land Is Our Land: An Immigrant’s Manifesto by Suketu Mehta The Truffle Underground: A Tale of Mystery, Mayhem, and Manipulation in the Shadowy Market of the World’s Most Expensive Fungus by Ryan Jacobs Naturally Tan: A Memoir by Tan France Formation: A Woman’s Memoir of Stepping Out of Line by Ryan Leigh Dostie Grace Will Lead Us Home: The Charleston Church Massacre and the Hard, Inspiring Journey to Forgiveness by Jennifer Berry Hawes The Last Pirate of New York: A Ghost Ship, a Killer, and the Birth of a Gangster Nation by Rich Cohen Blonde Rattlesnake: Burmah Adams, Tom White, and the 1933 Crime Spree That Terrorized Los Angeles by Julia Bricklin Mamaskatch: A Cree Coming of Age by Darrel J. McLeod Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban Pride Month Real Queer America: LGBT Stories from Red States by Samantha Allen Native Country of the Heart: A Memoir by Cherrie Moraga Prairie Silence: A Memoir by Melanie Hoffert The Pink Triangle: The Nazi War Against Homosexuals by Richard Plant We Have Always Been Here: A Queer Muslim Memoir by Samra Habib Indecent Advances: A Hidden History of True Crime and Prejudice Before Stonewall by James Polchin The Stonewall Riots: Coming Out in the Streets by Gayle E Pitman Reading Now KIM: Small Fry by Lisa Brennan-Jobs ALICE: The Disappearing Spoon by Sam Kean CONCLUSION You can find us on SOCIAL MEDIA – @itsalicetime and @kimthedork RATE AND REVIEW on ITUNES so people can find us more easily, and subscribe so you can get our new episodes the minute they come out.
My mother used to tell me when I was a kid that coffee would stunt my growth. But seriously, can coffee do that? Can coffee sober you up if you are drunk? This episode begins with a look at what coffee can and cannot do. http://lifehacker.com/four-popular-coffee-myths-debunked-by-science-1780764499We’ve all been told that generic drugs are equivalent to name brand drugs at a fraction of the price. Well, not necessarily. Most generic drugs are made in India and China and oversight by the FDA is not as great as you think. Investigative journalist Katherine Eban has just published an explosive expose that tells a troubling story about the safety and effectiveness of generic drugs. The book is called Bottle of Lies: The Inside Story of the Generic Drug Boom (https://amzn.to/2K1f6Vm). If you or someone you know takes prescription drugs, you need to hear this. Katherine’s website is www.KatherineEban.com Too much sun is a problem. But so is too little sun. It turns out there is strong medical evidence that some sun is good for your health. Listen to hear how much and what it is good for. (http://www.rd.com/health/wellness/sun-affects-your-body/)Choosing on a career path and finding the right job is a haphazard experience for a lot of us. However, there is actually some science behind how to find a job, do it well and move up the ladder. One of the leading expert in this field is Art Markman, professor of Psychology and Marketing at the University of Texas at Austin and author of the new book Bring Your Brain To Work: Using Cognitive Science to Get a Job, Do It Well and Advance Your Career (https://amzn.to/2WpTbc6). Art joins me for a fascinating look at a better way to find professional success.This Week’s Sponsors-SimpliSafe. For free shipping and a 60 day risk-free trial go to www.SimpliSafe.com/something-Stroke of Genius Podcast. Subscribe to Stroke of Genius on Apple Podcasts, at www.ipoef.org, or your favorite podcast platform.-Lively. For $10 off your first order go to www.WearLively.com/something and use promo code: something-Linzess. For information about your IBSC symptoms go to www.ohmygut.info/podcast.-Capital One. What's in your wallet? www.CapitalOne.com-Geico. Save 15% or more on car insurance at www.Geico.com
When you’re getting ready to buy most anything -- from a car to a new phone -- you’re likely to think long and hard about where you spend your money. But when it comes to the medications we take, most of us just buy whatever’s cheapest without ever really giving it a second thought. But should we? On this edition of In Depth we speak with investigative journalist and author Katherine Eban about her new book, "Bottle of Lies: The Inside Story of the Generic Drug Boom." Eban's reporting sheds light on the often opaque world of drug manufacture -- a world that has grown even more opaque as more of that manufacturing work has been moved overseas -- and suggests that inadequate regulation is putting patients taking generic drugs at serious risk. Host: KCBS Radio reporter Keith Menconi
This week, Liberty and Kelly discuss The Den, There's Something about Sweetie , Lanny , and more great books. This episode was sponsored by Amazon Kindle Unlimited, Lost In You by Lauren Dane , and ThirdLove. Pick up an All the Books! 200th episode commemorative item here. Subscribe to All the Books! using RSS or iTunes and never miss a beat book. Sign up for the weekly New Books! newsletter for even more new book news. Books discussed on the show: Lanny by Max Porter Rabbits for Food by Binnie Kirshenbaum The Den: A novel by Abi Maxwell There's Something about Sweetie by Sandhya Menon The Candle and the Flame by Nafiza Azad Black Death at the Golden Gate: The Race to Save America from the Bubonic Plague by David K. Randall No Saving Throw by Kristin McFarland A Place to Belong by Cynthia Kadohata and Julia Kuo What we're reading: Let Me Hear a Rhyme by Tiffany D Jackson The Truffle Underground: A Tale of Mystery, Mayhem, and Manipulation in the Shadowy Market of the World's Most Expensive Fungus by Ryan Jacobs More books out this week: Once More We Saw Stars: A Memoir by Jayson Greene The Lost Coast by Amy Rose Capetta Not Bad People by Brandy Scott Manfried Saves the Day: A Graphic Novel by Caitlin Major and Kelly Bastow Planet Earth Is Blue by Nicole Panteleakos Deep Past: A Novel by Eugene Linden Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban The Key to Happily Ever After by Tif Marcelo Testimony from Your Perfect Girl by Kaui Hart Hemmings Dream Sequence: A Novel by Adam Foulds Brothers Down: Pearl Harbor and the Fate of the Many Brothers Aboard the USS Arizona by Walter R. Borneman Dawson's Fall: A Novel by Roxana Robinson Floyd Harbor: Stories by Joel Mowdy The Song of the Jade Lily: A Novel by Kirsty Manning The Undefeated by Una McCormack Offline Journal: An Illustrated Guide for a more Connected, Creative Life by Jaya Nicely My Ex-Best Friend's Wedding by Wendy Wax Transformed: A Navy SEAL’s Unlikely Journey from the Throne of Africa, to the Streets of the Bronx, to Defying All Odds by Remi Adeleke The Killer You Know by S.R. Masters Strangers and Cousins: A Novel by Leah Hager Cohen Life of David Hockney: A Novel by Catherine Cusset, Teresa Fagan (translator) The Satapur Moonstone (A Perveen Mistry Novel) by Sujata Massey We Contain Multitudes by Sarah Henstra The Scholar: A Novel by Dervla McTiernan The Obsoletes: A Novel by Simeon Mills Don't Date Rosa Santos by Nina Moreno Shut Up You're Pretty by Téa Mutonji We Hunt the Flame by Hafsah Faizal York: The Clockwork Ghost by Laura Ruby The Desert Sky Before Us: A Novel by Anne Valente The Printed Letter Bookshop by Katherine Reay A Brightness Long Ago by Guy Gavriel Kay Tears of the Trufflepig: A Novel by Fernando A. Flores Triangulum by Masande Ntshanga Once More unto the Breach by Meghan Holloway Hot Comb by Ebony Flowers The Night Window: A Jane Hawk Novel by Dean Koontz Time Sight by Lynne Jonell Red, White & Royal Blue: A Novel by Casey McQuiston Out East: Memoir of a Montauk Summer by John Glynn A Bend in the Stars by Rachel Barenbaum Naturally Tan: A Memoir by Tan France Glitch by Sarah Graley If She Wakes by Michael Koryta Stepsister by Jennifer Donnelly Freedom Fire (Dactyl Hill Squad #2) by Daniel José Older The British Are Coming: The War for America, Lexington to Princeton, 1775-1777 (The Revolution Trilogy) by Rick Atkinson America Was Hard to Find by Kathleen Alcott Rules for Visiting: A Novel by Jessica Francis Kane Home Remedies by Xuan Juliana Wang You Will Be Safe Here by Damian Barr The Night Before by Wendy Walker Lima :: Limon by Natalie Scenters-Zapico Apollo's Legacy: Perspectives on the Moon Landings by Roger D. Launius Beyond Babylon by Igiaba Scego, Aaron Robertson The Unhoneymooners by Christina Lauren Mind and Matter: A Life in Math and Football by John Urschel and Louisa Thomas Spying on the South: An Odyssey Across the American Divide by Tony Horwitz The Things She's Seen by Ambelin Kwaymullina and Ezekiel Kwaymullina The Case for Space: How the Revolution in Spaceflight Opens Up a Future of Limitless Possibility by Robert Zubrin Odd Gods by David Slavin, Daniel Weitzman Hybrida: Poems by Tina Chang Orange World and Other Stories by Karen Russell Disappearing Earth by Julia Phillips Son of Havana: A Baseball Journey from Cuba to the Big Leagues and Back by Luis Tiant On a Scale of One to Ten by Ceylan Scott Nirvana Is Here: A Novel by Aaron Hamburger The First Wave: The D-Day Warriors Who Led the Way to Victory in World War II by Alex Kershaw Everything Is F*cked: A Book About Hope by Mark Manson If You Cross the River: A Novel by Geneviéve Damas and Jody Gladding
A in-depth look into A Landscape of Lies feature film which was the subject of a £19.6M tax fraud that has risen from the flames to be released 7 years later.. Unbeknownst to Director Paul Knight, who has proved his innocence in court, of the scam that would send the producers to jail for 20 years while he was trying to make his low budget feature has now re cut the film and prepared it for release. Paul chats with Giles Alderson (The Dare) and Christian James (Fanged Up) about the journey, the fraud and the jail time the ‘exec producers' received and his amazing tenacity to get his film seen by the world. This a wonderful, insight, warts and all account of a horror story that all filmmakers fear. The film will be available from March 2018 Follow Paul Knight here: @Lndnknts Follow the Filmmakers Podcast here: www.thefilmmakerspodcast.com Twitter @filmmakerspod @gilesalderson @CJamesdirect
© 2020-2025 Ivy Podcast Discovery LLC
